Home > Healthcare > Medical Devices > Therapeutic Devices > Endotherapy Devices Market

Endotherapy Devices Market Size

  • Report ID: GMI3782
  • Published Date: Jul 2024
  • Report Format: PDF

Endotherapy Devices Market Size

Endotherapy Devices Market size was valued at USD 4.8 billion in 2023 and is anticipated to grow at a CAGR of 7.8% between 2024 and 2032, driven by the rising incidence of gastrointestinal conditions, increasing preference for minimally invasive procedures, and increasing awareness towards early diagnosis and treatment of GI disorders.

 

Gastrointestinal diseases, including conditions such as inflammatory bowel disease (IBD), colorectal cancer, gastroesophageal reflux disease (GERD), and peptic ulcers, are becoming increasingly prevalent worldwide. For instance, according to the Centers for Disease Control and Prevention (CDC), in 2023, about 7 million people worldwide were estimated to have IBD. With the rising incidence of GI conditions, there is a corresponding increase in the number of diagnostic and therapeutic procedures performed to manage these diseases.

 

Additionally, endotherapy devices enable minimally invasive procedures, which are preferred over traditional surgical methods due to their reduced risk, shorter recovery times, and lower healthcare costs. Patients with GI conditions increasingly opt for endoscopic treatments, such as polypectomy, mucosal resection, and stent placement, which are less invasive and offer quicker recovery. This preference for minimally invasive procedures boosts the market for endotherapy devices.

 

Endotherapy devices are specialized medical instruments and tools used in endoscopic procedures to diagnose, treat, and manage various gastrointestinal and respiratory conditions.

 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of endotherapy devices reached USD 4.8 billion in 2023 and is set to witness a CAGR of 7.8% through 2032, led by the rising incidence of gastrointestinal conditions, and increasing preference for minimally invasive procedures.

The gastrointestinal devices & accessories segment held a dominant market share of 56.6% in 2023, backed by increasing prevalence of GI disorders and the emphasis on early detection and screening programs.

North America market size was valued at USD 2.2 billion in 2023 and is predicted to record a CAGR of 7.5% through 2032, driven by advanced healthcare infrastructure, high medical expenditure, and the presence of leading medical device companies.

Conmed Corporation, Cook Medical, Fujifilm Corporation, Intuitive Surgical, Johnson & Johnson, Karl Storz, M.I. Tech Co Ltd, Medtronic plc, Olympus Corporation, and Richard Wolf GmbH among others.

Endotherapy Devices Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 277
  • Countries covered: 23
  • Pages: 120
 Download Free Sample